a multicentre double-blind comparative trial was performed in 138 patients with rheumatoid arthritis ( ra ) after biweekly intravenous or intramuscular injections of liposteroid ( containing 2.5 mg of dexamethasone ) , which had been developed as a drug for targeting therapy of ra , and decadron ( containing 3.3 mg of dexamethasone ) as a reference drug .
C0740057
decadron
C0011777
dexamethasone